Cargando…

Validation of Candidate Serum Ovarian Cancer Biomarkers for Early Detection

OBJECTIVE: We have previously analyzed protein profiles using Surface Enhanced Laser Desorption and Ionization Time-Of-Flight Mass Spectroscopy (SELDI-TOF-MS) [Kozak et al. 2003, Proc. Natl. Acad. Sci. U.S.A. 100:12343–8] and identified 3 differentially expressed serum proteins for the diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Feng, Lang, Jennifer, Kumar, Ashutosh, Ng, Carey, Hsieh, Brian, Suchard, Marc A., Reddy, Srinivasa T., Farias-Eisner, Robin
Formato:	Texto
Lenguaje:	English
Publicado:	Libertas Academica 2007
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717832/ https://www.ncbi.nlm.nih.gov/pubmed/19662218

Ejemplares similares

Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer
por: Devarajan, Asokan, et al.
Publicado: (2018)

A review of the effects of healthcare disparities on the experience and survival of ovarian cancer patients of different racial and ethnic backgrounds
por: Kaufman, Matthew, et al.
Publicado: (2019)

Quantitative proteomic analysis by iTRAQ(® )for the identification of candidate biomarkers in ovarian cancer serum
por: Boylan, Kristin LM, et al.
Publicado: (2010)

Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer
por: Dutt, Mriga, et al.
Publicado: (2023)

Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum
por: De La Franier, Brian, et al.
Publicado: (2020)

Validation of Serotransferrin in the Serum as Candidate Biomarkers for the Diagnosis of Pulmonary Tuberculosis by Label-Free LC/MS
por: Li, Xue, et al.
Publicado: (2022)

Identification of Novel Biomarkers and Candidate Drug in Ovarian Cancer
por: Li, Chia-Jung, et al.
Publicado: (2021)

A Novel HDL-Mimetic Peptide HM-10/10 Protects RPE and Photoreceptors in Murine Models of Retinal Degeneration
por: Su, Feng, et al.
Publicado: (2019)

Validation of biomarkers of food intake—critical assessment of candidate biomarkers
por: Dragsted, L. O., et al.
Publicado: (2018)

Candidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validation
por: Chen, Ying, et al.
Publicado: (2013)

Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice
por: Su, Feng, et al.
Publicado: (2020)

New Approaches and Biomarker Candidates for the Early Detection of Ovarian Cancer
por: Hossain, K. R., et al.
Publicado: (2022)

Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma
por: Arakawa, Noriaki, et al.
Publicado: (2016)

Alix: A Candidate Serum Biomarker of Alzheimer’s Disease
por: Sun, Yingni, et al.
Publicado: (2021)

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes
por: Hodgson, Darren R., et al.
Publicado: (2018)

Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
por: Ramadoss, S, et al.
Publicado: (2017)

Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma
por: Daugaard, Iben, et al.
Publicado: (2016)

Optimization of MicroCT Imaging and Blood Vessel Diameter Quantitation of Preclinical Specimen Vasculature with Radiopaque Polymer Injection Medium
por: Vasquez, Sergio X., et al.
Publicado: (2011)

Erratum: Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
por: Ramadoss, S, et al.
Publicado: (2017)

Identification of Candidate Biomarkers of Alzheimer’s Disease via Multiplex Cerebrospinal Fluid and Serum Proteomics
por: Liu, Ping, et al.
Publicado: (2023)

Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers
por: Yip, Ping, et al.
Publicado: (2011)

Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer
por: Seagle, Brandon-Luke L., et al.
Publicado: (2016)

Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing Spondylitis
por: Fischer, Roman, et al.
Publicado: (2012)

Identification of Candidate Serum Biomarkers for Schistosoma mansoni Infected Mice Using Multiple Proteomic Platforms
por: Kardoush, Manal I., et al.
Publicado: (2016)

Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer
por: Chattopadhyay, Arnab, et al.
Publicado: (2015)

Integrative analysis to select cancer candidate biomarkers to targeted validation
por: Kawahara, Rebeca, et al.
Publicado: (2015)

Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
por: Meunier, Lucy, et al.
Publicado: (2019)

Circulating microRNAs as candidate biomarkers for the ovarian response during in vitro fertilization
por: Zhao, Hongjuan, et al.
Publicado: (2021)

Best serum biomarker combination for ovarian cancer classification
por: Song, Hye-Jeong, et al.
Publicado: (2018)

Mannosylated lipoarabinomannan in serum as a biomarker candidate for subclinical bovine tuberculosis
por: Lamont, Elise A, et al.
Publicado: (2014)

Candidate Genes and Proteomic Biomarkers of Serum and Urine in Medication-Overuse Headache
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Serum-Derived Exosomal Proteins as Potential Candidate Biomarkers for Hepatocellular Carcinoma
por: Zhao, Liping, et al.
Publicado: (2021)

Are there candidates for high-dose chemotherapy in ovarian carcinoma?
por: Sabatier, Renaud, et al.
Publicado: (2012)

Panel of seven long noncoding RNA as a candidate prognostic biomarker for ovarian cancer
por: Zhan, Xiaohui, et al.
Publicado: (2017)

Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer
por: Lu, Haonan, et al.
Publicado: (2021)

Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer
por: Gyllensten, Ulf, et al.
Publicado: (2022)

A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer
por: Zhu, Huijun, et al.
Publicado: (2021)

A proteomic analysis identifies candidate early biomarkers to predict ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients
por: Wu, Lan, et al.
Publicado: (2017)

Current clinical application of serum biomarkers to detect ovarian cancer
por: Nowak, Marek, et al.
Publicado: (2015)

Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis
por: Kimura, Yayoi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0c0lc1k933lk806uslolllu6rg